Development of a cognitive-based smartphone application for Malaysian Parkinson's disease patients: Exploring the possibility?

Q4 Neuroscience Neuroscience Research Notes Pub Date : 2022-03-31 DOI:10.31117/neuroscirn.v5i1.126
Wael M. Y. Mohamed, S. K. Kutty, A. Khedher, Indranath Chatterjee
{"title":"Development of a cognitive-based smartphone application for Malaysian Parkinson's disease patients: Exploring the possibility?","authors":"Wael M. Y. Mohamed, S. K. Kutty, A. Khedher, Indranath Chatterjee","doi":"10.31117/neuroscirn.v5i1.126","DOIUrl":null,"url":null,"abstract":"The COVID-19 pandemic has accelerated the digital health system. Healthcare organizations want to give medical treatment to individuals who live a great distance away. As a result, they are emphasizing the creation of bespoke telemedicine apps. The number of individuals using telemedicine apps is increasing significantly. Increasing technology gives patients healthcare resources. This has been made feasible via a new telemedicine system and by developing a telemedicine app. Patients can use several technologies to communicate with healthcare professionals. For comfort and privacy, you can employ live visual media. The creation of telemedicine apps is the most attractive and practical investment. With the growing availability and usage of technology in PD, the focus of these technologies is gradually turning toward the disease's vast spectrum of Non-Motor Symptoms (NMS). The nature of NMS makes them difficult to objectively measure, further development and building on experience gained in other conditions may still result in NMS capture that is feasible. Although it is impossible to offer recommendations for the use of digital technology outcomes for NMS in clinical practise based on currently available data, evidence for these devices is evolving, and such guidance may become accessible in the not-too-distant future. To our knowledge, this is the first telemedicine method of its sort to address cognition as one of the NMS in Malay PD patients. The project will be done on two consecutive phases (1 year each); Phase1 aims to develop the Dementia Coach Mobile App, and Phase2 aims to validation of this app by using PD patients sample from SASMEC. Therefore, we hypothesize that developing a friendly mobile app to assess dementia for PD patients is highly beneficial and could be used for diagnosis of NMS in PD patients.","PeriodicalId":36108,"journal":{"name":"Neuroscience Research Notes","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroscience Research Notes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31117/neuroscirn.v5i1.126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Neuroscience","Score":null,"Total":0}
引用次数: 1

Abstract

The COVID-19 pandemic has accelerated the digital health system. Healthcare organizations want to give medical treatment to individuals who live a great distance away. As a result, they are emphasizing the creation of bespoke telemedicine apps. The number of individuals using telemedicine apps is increasing significantly. Increasing technology gives patients healthcare resources. This has been made feasible via a new telemedicine system and by developing a telemedicine app. Patients can use several technologies to communicate with healthcare professionals. For comfort and privacy, you can employ live visual media. The creation of telemedicine apps is the most attractive and practical investment. With the growing availability and usage of technology in PD, the focus of these technologies is gradually turning toward the disease's vast spectrum of Non-Motor Symptoms (NMS). The nature of NMS makes them difficult to objectively measure, further development and building on experience gained in other conditions may still result in NMS capture that is feasible. Although it is impossible to offer recommendations for the use of digital technology outcomes for NMS in clinical practise based on currently available data, evidence for these devices is evolving, and such guidance may become accessible in the not-too-distant future. To our knowledge, this is the first telemedicine method of its sort to address cognition as one of the NMS in Malay PD patients. The project will be done on two consecutive phases (1 year each); Phase1 aims to develop the Dementia Coach Mobile App, and Phase2 aims to validation of this app by using PD patients sample from SASMEC. Therefore, we hypothesize that developing a friendly mobile app to assess dementia for PD patients is highly beneficial and could be used for diagnosis of NMS in PD patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
为马来西亚帕金森病患者开发基于认知的智能手机应用程序:探索可能性?
新冠肺炎疫情加速了数字卫生系统的发展。医疗保健组织希望为居住在很远地方的个人提供医疗服务。因此,他们强调创建定制的远程医疗应用程序。使用远程医疗应用程序的人数正在显著增加。不断增长的技术为患者提供了医疗资源。这是通过一个新的远程医疗系统和开发远程医疗应用程序实现的。患者可以使用多种技术与医疗保健专业人员交流。为了舒适和隐私,您可以使用现场视觉媒体。创建远程医疗应用程序是最具吸引力和实用性的投资。随着帕金森病技术的可用性和使用率不断提高,这些技术的重点正逐渐转向该疾病的广泛非运动症状(NMS)。NMS的性质使其难以客观测量,在其他条件下获得的经验的基础上进行进一步开发和建设可能仍然会导致NMS捕获是可行的。尽管根据目前可用的数据,不可能为NMS在临床实践中使用数字技术成果提供建议,但这些设备的证据正在演变,这种指导可能在不久的将来变得可用。据我们所知,这是第一种将认知作为马来PD患者NMS之一的远程医疗方法。该项目将分两个连续阶段进行(每个阶段1年);第一阶段旨在开发痴呆症教练移动应用程序,第二阶段旨在通过使用SASMEC的PD患者样本来验证该应用程序。因此,我们假设开发一个友好的移动应用程序来评估PD患者的痴呆症是非常有益的,可以用于诊断PD患者的NMS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neuroscience Research Notes
Neuroscience Research Notes Neuroscience-Neurology
CiteScore
1.00
自引率
0.00%
发文量
21
期刊最新文献
Comparative retrospective analysis: exploring the quality of life of people with epilepsy in two cohorts Default mode network perturbations in Alzheimer's disease: an fMRI study in Klang Valley, Malaysia Gene expression analysis in plasma of patients with Alzheimer's disease Psychological science in Mongolia: Its history, development, and future prospects Neuroinflammation-induced neurodegeneration and associated microglia activation in Parkinson’s disease: a novel neurotherapeutic avenue
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1